Download PDF
Endoscopy 1999; 31(6): 472-478
DOI: 10.1055/s-1999-47
Review
Georg Thieme Verlag Stuttgart ·New York

Management of Duodenal Adenomas in Familial Adenomatous Polyposis

J. C. Saurin, J. A. Chayvialle, T. Ponchon
  • Fédération des Spécialités Digestives, Hôpital Edouard Herriot, Lyon
Further Information

Publication History

Publication Date:
31 December 1999 (online)

Also available at
    Permissions and Reprints

Introduction

Familial adenomatous polyposis (FAP) is an uncommon inherited disease, found in about 1/8000 births, which leads to the development of adenomas throughout the glandular digestive mucosa. The main complication of this disease is colorectal cancer, which is prevented by prophylactic colectomy carried out in most patients during the third decade. After colectomy, these patients remain at risk for life-threatening complications related to the disease. The two major complications are desmoid tumors (mesenchymal, nonmalignant, mostly mesenteric, slow-growing tumors), and duodenal adenocarcinomas, mostly periampullary [1] [2] . These probably develop from duodenal adenomas, which are present in the large majority of FAP patients. In clinical practice, there is a strong contradiction between the recommended endoscopic surveillance of duodenal adenomas, which demonstrates their evolving nature, and the lack of therapeutic indications until the development of late-stage polyposis which may require pancreaticoduodenectomy.

References

  • 1 Nugent K P, Spigelman A D, Phillips R K. Life expectancy after colectomy and iliorectal anastomosis for familial adenomatous polyposis.  Dis Colon Rectum. 1993;  36 1059-1062
    PubMedGoogle Scholar
  • 2 Jagelman D G, DeCosse J J, Bussey H J. Upper gastrointestinal cancer in familial adenomatous polyposis.  Lancet. 1988;  1 1149-1151
    PubMedGoogle Scholar
  • 3 Vasen H F, Bulow S, Myrhoj T, et al. Decision analysis in the management of duodenal adenomatosis in familial adenomatous polyposis.  Gut. 1997;  40 716-719
    CrossrefPubMedGoogle Scholar
  • 4 Arvanitis M L, Jagelman D G, Fazio V W, et al. Mortality in patients with familial adenomatous polyposis.  Dis Colon Rectum. 1990;  33 639-642
    CrossrefPubMedGoogle Scholar
  • 5 Nugent K P, Spigelman A D, Williams C B, et al. Surveillance of duodenal polyps in familial adenomatous polyposis: progress report.  J Royal Soc Med. 1994;  87 704-706
    PubMedGoogle Scholar
  • 6 Spigelman A D, Williams C B, Talbot I C, et al. Upper gastrointestinal cancer in patients with familial adenomatous polyposis.  Lancet. 1989;  2 783-785
    PubMedGoogle Scholar
  • 7 Nakatsubo N, Kashiwagi H, Okumura M, et al. Malignant change in a duodenal adenoma in familial adenomatous polyposis: report of a case.  Am J Gastroenterol. 1998;  93 1566-1568
    PubMedGoogle Scholar
  • 8 Sawada T, Muto T. Familial adenomatous polyposis: should patients undergo surveillance of the upper gastrointestinal tract?.  Endoscopy. 1995;  27 6-11
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Richard C S, Berk T, Bapat B V, et al. Sulindac for periampullary polyps in FAP patients.  Int J Colorectal Dis. 1997;  12 14-18
    PubMedGoogle Scholar
  • 10 Nugent K P, Spigelman A D, Williams C B, et al. Follow-up in familial adenomatous polyposis.  Lancet. 1993;  341 1225
    PubMedGoogle Scholar
  • 11 Iida M, Yao T, Itoh H, et al. Natural history of duodenal lesions in Japanese patients with familial adenomatosis coli (Gardner's syndrome).  Gastroenterology. 1989;  96 1301-1306
    CrossrefPubMedGoogle Scholar
  • 12 Kashiwagi H, Spigelman A D, Debinski H S, et al. Surveillance of ampullary adenomas in familial adenomatous polyposis.  Lancet. 1994;  344 1582
    PubMedGoogle Scholar
  • 13 Beckwith P S, van Heerden J A, Dozois R R, et al. Prognosis of symptomatic duodenal adenomas in familial adenomatous polyposis.  Arch Surg. 1991;  126 825-827, discussion 7 - 8
    PubMedGoogle Scholar
  • 14 Debinski H S, Spigelman A D, Hatfield A, et al. Upper intestinal surveillance in familial adenomatous polyposis.  Eur J Cancer. 1995;  31A 1149-1153
    PubMedGoogle Scholar
  • 15 Spigelman A D, Hodgson S V, Thomson J P. Management of familial adenomatous polyposis.  Baillières Clin Gastroenterol. 1992;  6 75-94
    PubMedGoogle Scholar
  • 16 Hirasawa R, Iishi H, Tatsuta M, et al. Clinicopathologic features and endoscopic resection of duodenal adenocarcinomas and adenomas with the submucosal saline injection technique.  Gastrointest Endosc. 1997;  46 507-513
    CrossrefPubMedGoogle Scholar
  • 17 Fenoglio C M, Kaye G I, Lane N. Distribution of human colonic lymphatics in normal, hyperplastic, and adenomatous tissue. Its relationship to metastasis from small carcinomas in pedunculated adenomas, with two case reports.  Gastroenterology. 1973;  64 51-66
    PubMedGoogle Scholar
  • 18 Witteman B J, Janssens A R, Griffioen G, et al. Villous tumours of the duodenum. An analysis of the literature with emphasis on malignant transformation.  Neth J Med. 1993;  42 5-11
    PubMedGoogle Scholar
  • 19 Iwama T, Tomita H, Kawachi Y, et al. Indications for local excision of ampullary lesions associated with familial adenomatous polyposis.  J Am Coll Surg. 1994;  179 462-464
    PubMedGoogle Scholar
  • 20 Bjork K J, Davis C J, Nagorney D M, et al. Duodenal villous tumors.  Arch Surg. 1990;  125 961-965
    PubMedGoogle Scholar
  • 21 Bleau B L, Gostout C J. Endoscopic treatment of ampullary adenomas in familial adenomatous polyposis.  J Clin Gastroenterol. 1996;  22 237-241
    CrossrefPubMedGoogle Scholar
  • 22 Penna C, Phillips R K, Tiret E, et al. Surgical polypectomy of duodenal adenomas in familial adenomatous polyposis: Experience of two European centres.  Br J Surg. 1993;  80 1027-1029
    CrossrefPubMedGoogle Scholar
  • 23 Causeret S, Francois Y, Griot J B, et al. Prophylactic pancreaticoduodenectomy for premalignant duodenal polyposis in familial adenomatous polyposis.  Int J Colorectal Dis. 1998;  13 39-42
    CrossrefPubMedGoogle Scholar
  • 24 Penna C, Bataille N, Balladur P, et al. Surgical treatment of severe duodenal polyposis in familial adenomatous polyposis.  Br J Surg. 1998;  85 665-668
    CrossrefPubMedGoogle Scholar
  • 25 Brunetaud J M, Mosquet L, Houcke M, et al. Villous adenomas of the rectum. Results of endoscopic treatment with argon and Nd : YAG lasers.  Gastroenterology. 1985;  89 832-837
    PubMedGoogle Scholar
  • 26 Mathus-Vliegen E M, Tytgat G N. Analysis of failures and complications of neodymium : Yag laser photocoagulation in gastrointestinal tract tumors. A retrospective survey of 18 years' experience.  Endoscopy. 1990;  22 17-23
    PubMedGoogle Scholar
  • 27 Low D E, Kozarek R A, Ball T J, et al. Nd-YAG laser photoablation of sessile villous and tubular adenomas of the colorectum.  Ann Surg. 1988;  208 725-732
    PubMedGoogle Scholar
  • 28 Ghilain J M, Dive C. Endoscopic laser therapy for small villous adenomas of the duodenum.  Endoscopy. 1994;  26 308-310
    PubMedGoogle Scholar
  • 29 Paraf F, Naveau S, Zourabichvili O, et al. Endoscopic laser therapy for duodenal villous adenoma.  Dig Dis Sci. 1989;  34 1466-1467
    CrossrefPubMedGoogle Scholar
  • 30 Ponchon T, Berger F, Chavaillon A, et al. Contribution of endoscopy to diagnosis and treatment of tumors of the ampulla of Vater.  Cancer. 1989;  64 161-167
    CrossrefPubMedGoogle Scholar
  • 31 van Stolk R, Sivak M V Jr, Petrini J L, et al. Endoscopic management of upper gastrointestinal polyps and periampullary lesions in familial adenomatous polyposis and Gardner's syndrome.  Endoscopy. 1987;  19 (Suppl. 1) 19-22
    PubMedGoogle Scholar
  • 32 Mlkvy P, Messmann H, Debinski H, et al. Photodynamic therapy for polyps in familial adenomatous polyposis - a pilot study.  Eur J Cancer. 1995;  31A 1160-1165
    PubMedGoogle Scholar
  • 33 Wahab P J, Mulder C J, den Hartog G, et al. Argon plasma coagulation in flexible gastrointestinal endoscopy: pilot experiences.  Endoscopy. 1997;  29 176-181
    Article in Thieme ConnectPubMedGoogle Scholar
  • 34 Yokota T, Sugihara K, Yoshida S. Endoscopic mucosal resection for colorectal neoplastic lesions.  Dis Colon Rectum. 1994;  37 1108-1111
    CrossrefPubMedGoogle Scholar
  • 35 Kudo S. Endoscopic mucosal resection of flat and depressed types of early colorectal cancer.  Endoscopy. 1993;  25 455-461
    Article in Thieme ConnectPubMedGoogle Scholar
  • 36 Binmoeller K F, Boaventura S, Ramsperger K, et al. Endoscopic snare excision of benign adenomas of the papilla of Vater.  Gastrointest Endosc. 1993;  39 127-131
    CrossrefPubMedGoogle Scholar
  • 37 Oohara T, Ogino A, Saji K, et al. Studies on the difference of background mucosa among single advanced carcinoma and benign diseases of the large intestine, and familial polyposis coli.  Cancer. 1980;  45 1637-1645
    PubMedGoogle Scholar
  • 38 Strasberg S M, Drebin J A, Soper N J. Evolution and current status of the Whipple procedure: an update for gastroenterologists.  Gastroenterology. 1997;  113 983-994
    PubMedGoogle Scholar
  • 39 Nyam D C, Brillant P T, Dozois R R, et al. Ileal pouch-anal canal anastomosis for familial adenomatous polyposis: early and late results.  Ann Surg. 1997;  226 514-519, discussion 9 - 21
    CrossrefPubMedGoogle Scholar
  • 40 Penna C P, Tiret E, Kartheuser A H, et al. Comparison of functional results of ileorectal and ileo-anal anastomoses in familial adenomatous polyposis. Conversions of ileorectal anastomoses into ileo-anal anastomoses.  Gastroenterol Clin Biol. 1992;  16 401-405
    PubMedGoogle Scholar
  • 41 Piazza G A, Rahm A K, Finn T S, et al. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.  Cancer Res. 1997;  57 2452-2459
    PubMedGoogle Scholar
  • 42 Oshima M, Dinchuk J E, Kargman S L, et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).  Cell. 1996;  87 803-809
    CrossrefPubMedGoogle Scholar
  • 43 Nugent K P, Farmer K C, Spigelman A D, et al. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.  Br J Surg. 1993;  80 1618-1619
    PubMedGoogle Scholar
  • 44 Spagnesi M T, Tonelli F, Dolara P, et al. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.  Gastroenterology. 1994;  106 362-366
    PubMedGoogle Scholar
  • 45 Giardiello F M, Hamilton S R, Krush A J, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.  N Engl J Med. 1993;  328 1313-1316
    CrossrefPubMedGoogle Scholar
  • 46 Pasricha P J, Bedi A, O'Connor K, et al. The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis.  Gastroenterology. 1995;  109 994-998
    PubMedGoogle Scholar
  • 47 Ishikawa H, Akedo I, Suzuki T, et al. Adverse effects of sulindac used for prevention of colorectal cancer.  J Natl Cancer Inst. 1997;  89 1381
    CrossrefPubMedGoogle Scholar
  • 48 Niv Y, Fraser G M. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy.  Gastroenterology. 1994;  107 854-857
    PubMedGoogle Scholar
  • 49 Lynch H T, Thorson A G, Smyrk T, et al. Rectal cancer after prolonged sulindac chemoprevention. A case report.  Cancer. 1995;  75 936-938
    PubMedGoogle Scholar
  • 50 Gossner L, Stolte M, Sroka R, et al. Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.  Gastroenterology. 1998;  114 448-455
    PubMedGoogle Scholar
  • 51 Regula J, MacRobert A J, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX - a pilot study.  Gut. 1995;  36 67-75
    PubMedGoogle Scholar
  • 52 Loh C S, Bliss P, Bown S G, et al. Photodynamic therapy for villous adenomas of the colon and rectum.  Endoscopy. 1994;  26 243-246
    PubMedGoogle Scholar
  • 53 Lightdale C J, Heier S K, Marcon N E, et al. Photodynamic therapy for porfimer sodium versus thermal ablation therapy with Nd : YAG laser for palliation of esophageal cancer: a multicenter randomized trial.  Gastrointest Endosc. 1995;  42 507-512
    CrossrefPubMedGoogle Scholar
  • 54 Sibille A, Lambert R, Souquet J C, et al. Longterm survival after photodynamic therapy for esophageal cancer.  Gastroenterology. 1995;  108 337-344
    PubMedGoogle Scholar
  • 55 Tajiri H, Daikuzono N, Joffe S N, et al. Photoradiation therapy in early gastrointestinal cancer.  Gastrointest Endosc. 1987;  33 88-90
    PubMedGoogle Scholar
  • 56 Mlkvy P, Messmann H, Regula J, et al. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study.  Neoplasma. 1995;  42 109-113
    PubMedGoogle Scholar
  • 57 Mathus-Vliegen E M, Tytgat G N. The potential and limitations of laser photoablation of colorectal adenomas.  Gastrointest Endosc. 1991;  37 9-17
    PubMedGoogle Scholar

J. C. SaurinM.D. 

Fédération des Spécialités Digestives

Hôpital Edouard Herriot

Pavillon O

5 place d'Arsonval

69437 Lyon Cedex

France

Phone: + 33-472-110147

Email: saurin@lyon151.inserm.fr

      >